Christopher J Lord

43PUBLICATIONS
354CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursCancer geneticsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Jul 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

|Jun 02, 2026
Nucleophagy removes cytotoxic trapped PARP1.

|May 06, 2026
Two decades of PARP inhibitor synthetic lethality in cancer.

|Mar 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

Pageof 8

Frequent Collaborators

22 joint publications

Stephen Pettitt

16 joint publications

Andrew Tutt

15 joint publications

Syed Haider

12 joint publications

Jyoti S Choudhary